Global C Difficile Infection Drug Market Analysis 2013-2018 and Forecast 2019-2024

Table of Contents

1 Industry Overview

• 1.1 C Difficile Infection Drug Industry
  • 1.1.1 Overview
  • 1.1.2 Development of C Difficile Infection Drug
• 1.2 Market Segment
  • 1.2.1 Upstream
  • 1.2.2 Downstream
• 1.3 Cost Analysis

2 Industry Environment (PEST Analysis)

• 2.1 Policy
• 2.2 Economics
• 2.3 Sociology
• 2.4 Technology

3 C Difficile Infection Drug Market by Type

• 3.1 By Type
  • 3.1.1 Metronidazole
  • 3.1.2 Vancomycin
  • 3.1.3 Fidaxomycin
  • 3.1.4 Others
• 3.2 Market Size
• 3.3 Market Forecast

4 Major Companies List

4.C Difficile Infection Drug Merck (Company Profile, Sales Data etc.)

• 4.2 Astellas (Company Profile, Sales Data etc.)
• 4.3 Eli Lilly (Company Profile, Sales Data etc.)
• 4.4 ANI Pharmaceutical (Company Profile, Sales Data etc.)
• 4.5 Flynn Pharma (Company Profile, Sales Data etc.)
• 4.6 Aspen Pharmacare (Company Profile, Sales Data etc.)
• 4.7 Akorn (Company Profile, Sales Data etc.)
• 4.8 Merus labs (Company Profile, Sales Data etc.)
• 4.9 Pfizer (Company Profile, Sales Data etc.)
• 4.10 AstraZeneca (Company Profile, Sales Data etc.)
• 4.11 Strides (Company Profile, Sales Data etc.)
• 4.12 Sanofi (Company Profile, Sales Data etc.)
• 4.13 Fresenius (Company Profile, Sales Data etc.)
• 4.14 Xellia (Company Profile, Sales Data etc.)
• 4.15 Zhejiang Medicine (Company Profile, Sales Data etc.)
• 4.16 Lupin (Company Profile, Sales Data etc.)

5 Market Competition

• 5.1 Company Competition
• 5.2 Regional Market by Company

6 Demand by End Market

• 6.1 Demand Situation
  • 6.1.1 Demand in Pre-treatment
  • 6.1.2 Demand in Mid-term treatment
  • 6.1.3 Demand in Others
• 6.2 Regional Demand Comparison
• 6.3 Demand Forecast

7 Region Operation

• 7.1 Regional Production
• 7.2 Regional Market
• 7.3 by Region
  • 7.3.1 North America
    • 7.3.1.1 Overview
    • 7.3.1.2 by Country (U.S., Canada, Mexico)
  • 7.3.2 Europe
    • 7.3.2.1 Overview
    • 7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
  • 7.3.3 Asia-Pacific
    • 7.3.3.1 Overview
    • 7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
  • 7.3.4 South America
    • 7.3.4.1 Overview
    • 7.3.4.2 by Country (Brazil, Argentina etc.)
  • 7.3.5 Middle East & Africa
    • 7.3.5.1 Overview
    • 7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
• 7.4 Regional Import & Export
• 7.5 Regional Forecast

8 Marketing & Price

• 8.1 Price and Margin
  • 8.1.1 Price Trends
  • 8.1.2 Factors of Price Change
  • 8.1.3 Manufacturers Gross Margin Analysis
• 8.2 Marketing Channel

9 Research Conclusion

List of Tables

Table Upstream Segment of C Difficile Infection Drug

Table Application Segment of C Difficile Infection Drug

Table Global C Difficile Infection Drug Market 2013-2024, by Application, in USD Million

Table Major Company List of Metronidazole

Table Major Company List of Vancomycin

Table Major Company List of Fidaxomycin

Table Major Company List of Others

Table Global C Difficile Infection Drug Market 2013-2018, by Type, in USD Million

Table Global C Difficile Infection Drug Market 2013-2018, by Type, in Volume

Table Global C Difficile Infection Drug Market Forecast 2019-2024, by Type, in USD Million

Table Global C Difficile Infection Drug Market Forecast 2019-2024, by Type, in Volume

Table Merck Overview List

Table C Difficile Infection Drug Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Astellas Overview List

Table C Difficile Infection Drug Business Operation of Astellas (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Eli Lilly Overview List

Table C Difficile Infection Drug Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table ANI Pharmaceutical Overview List

Table C Difficile Infection Drug Business Operation of ANI Pharmaceutical (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Flynn Pharma Overview List

Table C Difficile Infection Drug Business Operation of Flynn Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Aspen Pharmacare Overview List

Table C Difficile Infection Drug Business Operation of Aspen Pharmacare (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Akorn Overview List

Table C Difficile Infection Drug Business Operation of Akorn (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Merus labs Overview List

Table C Difficile Infection Drug Business Operation of Merus labs (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Pfizer Overview List

Table C Difficile Infection Drug Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table AstraZeneca Overview List

Table C Difficile Infection Drug Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Strides Overview List

Table C Difficile Infection Drug Business Operation of Strides (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Sanofi Overview List

Table C Difficile Infection Drug Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Fresenius Overview List

Table C Difficile Infection Drug Business Operation of Fresenius (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Xellia Overview List

Table C Difficile Infection Drug Business Operation of Xellia (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Zhejiang Medicine Overview List

Table C Difficile Infection Drug Business Operation of Zhejiang Medicine (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Lupin Overview List

Table C Difficile Infection Drug Business Operation of Lupin (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)

Table Global C Difficile Infection Drug Sales Revenue 2013-2018, by Company, in USD Million

Table Global C Difficile Infection Drug Sales Revenue Share, by Company, in USD Million

Table Global C Difficile Infection Drug Sales Volume 2013-2018, by Company, in Volume

Table Global C Difficile Infection Drug Sales Volume Share 2013-2018, by Company, in Volume

Table Major Consumers List and Overview

Table Regional Demand Comparison List

Table Major Application in Different Regions

Table C Difficile Infection Drug Demand Forecast 2019-2024, by Application, in USD Million

Table C Difficile Infection Drug Demand Forecast 2019-2024, by Application, in Volume

Table C Difficile Infection Drug Production 2013-2018, by Region, in USD Million

Table C Difficile Infection Drug Production 2013-2018, by Region, in Volume

Table Global C Difficile Infection Drug Market 2013-2018, by Region, in USD Million

Table Global C Difficile Infection Drug Market Share 2013-2018, by Region, in USD Million

Table Global C Difficile Infection Drug Market 2013-2018, by Region, in Volume

Table Global C Difficile Infection Drug Market Share 2013-2018, by Region, in Volume

Table North America C Difficile Infection Drug Market Size 2013-2018, by Country, in USD Million

Table North America C Difficile Infection Drug Market Size 2013-2018, by Country, in Volume

Table Europe C Difficile Infection Drug Market Size 2013-2018, by Country, in USD Million

Table Europe C Difficile Infection Drug Market Size 2013-2018, by Country, in Volume

Table Asia-Pacific C Difficile Infection Drug Market Size 2013-2018, by Country, in USD Million

Table Asia-Pacific C Difficile Infection Drug Market Size 2013-2018, by Country, in Volume

Table South America C Difficile Infection Drug Market Size 2013-2018, by Country, in USD Million

Table South America C Difficile Infection Drug Market Size 2013-2018, by Country, in Volume

Table Middle East & Africa C Difficile Infection Drug Market Size 2013-2018, by Country, in USD Million

Table Middle East & Africa C Difficile Infection Drug Market Size 2013-2018, by Country, in Volume

Table C Difficile Infection Drug Market Forecast 2019-2024, by Region, in USD Million

Table C Difficile Infection Drug Market Forecast 2019-2024, by Region, in Volume

Table Price Factors List

List of Figures

Figure Global C Difficile Infection Drug Market Growth 2013-2018, by Type, in USD Million

Figure Global C Difficile Infection Drug Market Growth 2013-2018, by Type, in Volume

Figure North America C Difficile Infection Drug Market Concentration, in 2018

Figure Europe C Difficile Infection Drug Market Market Concentration, in 2018

Figure Asia-Pacific C Difficile Infection Drug MMarket Concentration, in 2018

Figure South America C Difficile Infection Drug Market Concentration, in 2018

Figure Middle East & Africa C Difficile Infection Drug Market Concentration, in 2018

Figure C Difficile Infection Drug Demand in Pre-treatment, 2013-2018, in USD Million

Figure C Difficile Infection Drug Demand in Pre-treatment, 2013-2018, in Volume

Figure C Difficile Infection Drug Demand in Mid-term treatment, 2013-2018, in USD Million

Figure C Difficile Infection Drug Demand in Mid-term treatment, 2013-2018, in Volume

Figure C Difficile Infection Drug Demand in Others, 2013-2018, in USD Million

Figure C Difficile Infection Drug Demand in Others, 2013-2018, in Volume

Figure North America C Difficile Infection Drug Market Size and Growth 2013-2018, in USD Million

Figure North America C Difficile Infection Drug Market Size and Growth 2013-2018, in Volume

Figure Europe C Difficile Infection Drug Market Size and Growth 2013-2018, in USD Million

Figure Europe C Difficile Infection Drug Market Size and Growth 2013-2018, in Volume

Figure Asia-Pacific C Difficile Infection Drug Market Size and Growth 2013-2018, in USD Million

Figure Asia-Pacific C Difficile Infection Drug Market Size and Growth 2013-2018, in Volume

Figure South America C Difficile Infection Drug Market Size and Growth 2013-2018, in USD Million

Figure South America C Difficile Infection Drug Market Size and Growth 2013-2018, in Volume

Figure Middle East & Africa C Difficile Infection Drug Market Size and Growth 2013-2018, in USD Million

Figure Middle East & Africa C Difficile Infection Drug Market Size and Growth 2013-2018, in Volume

Figure Marketing Channels Overview